Navigation Links
Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents
Date:5/20/2008

Sahajanand Medical Technologies received positive results of nine month PAINT trials for Drug eluting stents, Infinnium and Supralimus. The results

unveiled during plenary session of EuroPCR 2008-Barcelona.

SURAT, India, May 20 /PRNewswire/ -- Sahajanand Medical Technologies Pvt. Ltd. (SMT), Surat, India, leading developer and manufacturer of drug-eluting stents, welcomed the positive results of the prospective, randomized nine months results of PAINT trial (PercutAneous INTervention with biodegradable- polymer based paclitaxel-eluting, sirolimus-eluting, or bare stents for the treatment of de novo coronary lesions).

The PAINT study was designed with a unique 3-arm format that allows the evaluation of three stents that only differ on the presence and/or type of drug (all stents have exactly the same material, strut thickness and platform design). This distinguishes the study from other comparative trials that aimed to assess the differences between Sirolimus and Paclitaxel (having different polymers and different platform).

The study hypothesizes that two novel formulations of stents with Paclitaxel (Infinnium) or Sirolimus (Supralimus), eluted in biodegradable polymers, are effective in reducing neointimal proliferation in comparison with bare metal stents.

The nine month results of PAINT, which were unveiled on Tuesday May 13th during the plenary session of EuroPCR 2008 -- Barcelona, Spain, demonstrated that in comparison with bare metal stents, both formulations of biodegradable-polymer Paclitaxel-eluting ( Infinnium ) and Sirolimus -eluting (Supralimus) stents are effective in reducing neointimal proliferation and the risk of repeat intervention at 270 days, without increasing the incidence of death or myocardial infarction.

Primary investigator, Dr Pedro Lemos of the Heart Institute (InCor) University of Sao Paulo Medical School, Brazil, commented that, "The design of PAINT (2:2:1 randomization of 280 patient w
'/>"/>

SOURCE Sahajanand Medical Technologies Pvt. Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/6/2009)...6 The Michael J. Fox Fo...four industry research teams for pre-clinical rese...isease. , , The funding was awarded under the F... This program, first launched in 2006, supports an... research. TDI is part of MJFF,s focus on ,de-...
(Date:1/5/2009)... 5 Cylene Pharmaceuticals announce...rial of its oral CK2 protein kinase inhibitor, CX-...leman,s disease, or multiple myeloma. The primary ...termination of safety, tolerance and PK properties... Phase II trials. In addition, multiple mechanism-...
(Date:12/29/2008)...Dec. 29 The winner of t...tection was announced today by Dr. Peter G. Goldsc...ment Institute. , , The winner of the annual a... Cancer Center -- for its best practice " IND Re...ovides for 1) enhanced human subjects protection, ...
(Date:12/17/2008)... show for the first time that normal stem cells ca...ues , , MEMPHIS, Tenn., Dec. 17 /PRNewswire...s Research Hospital have answered a central questi...n give rise to tumors. Stem cells are immature cel...re differentiated cells that compose the range of ...
Breaking Medicine Technology:Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 32008 Human Research Protection Award Recipients Announced 2Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 2Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 33 D photonic crystals will revolutionize telecommunications 1888 13 D photonic crystals will revolutionize telecommunications 1888 23 D photonic crystals will revolutionize telecommunications 1888 3Acting Surgeon General Encourages Americans to Know Their Health History During Fourth Annual Family History Day 6757 1Acting Surgeon General Encourages Americans to Know Their Health History During Fourth Annual Family History Day 6757 2Acting Surgeon General Encourages Americans to Know Their Health History During Fourth Annual Family History Day 6757 3MEDRAD Mobile MR Injector Meets Challenges of MR Trailers 6755 1MEDRAD Mobile MR Injector Meets Challenges of MR Trailers 6755 2Franklin 26 Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 6753 1Franklin 26 Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 6753 2Franklin 26 Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 6753 3Franklin 26 Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 6753 4Franklin 26 Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 6753 5Franklin 26 Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 6753 6Franklin 26 Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 6753 7Franklin 26 Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 6753 8
(Date:1/8/2009)...ber Tom Torlakson Introduces AB 89 , , SACRAMEN...day, Lung Cancer Alliance-California (LCA-CA), hai...th District) for his continued leadership in intro...er research. For the third consecutive year, legi...ing considered in the California Legislature. ,...
(Date:1/8/2009)...dy could shape new treatments for secondary pneumo...wswire/ -- Scientists at St. Jude Children,s Resea...eatment for bacterial pneumonia following influenz... azithromycin, which kill bacteria by inhibiting t...standard first-line treatment with the "beta-lacta...
(Date:1/8/2009)...n hurtful comments, study suggests , , ...verestimate how strongly they would react to racis...ee percent of study participants at York Universit...iment with a white person rather than a black one,...about the black person when he left the room. ,...
(Date:1/8/2009)...ildren,s Research Hospital have demonstrated a mor...owing influenza. They found that the antibiotics c...y inhibiting their protein synthesis, are more eff...he "beta-lactam" antibiotic ampicillin, which caus...ng is important because pneumonia, rather than the...
Breaking Medicine News(10 mins):Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 3Health News:Many Turn Blind Eye to Racism 2Health News:Study finds more effective treatment for pneumonia following influenza 2Health News:Study finds more effective treatment for pneumonia following influenza 3
... had reported that the blood samples of autistic c...nents of the immunity system. This may be the firs... the blood tests of children. Autism spectrum diso... seen in a mild to the most sever form. The charac...
...hers say cholesterol may be actually needed to hel...ever researchers also say that too much of it coul...eries, where it builds up as plaque and can cause ...uggest an enzyme called ACAT2 may be to blame for ...
...regnancy not only decides the health// of the fetu...n as well. In a study to understand fetal developm...und out about long-term influence on the genetic c...ealth of the next few generations. Their research ...
... UK, has provided new guidelines //for dealing wit...uidelines suggest that psychological therapy be gi...ral or man made is always tough. NICE had emphasiz...thing shelter to these traumatized people it is al...
Other Medicine News:
Vannas Capsulotomy scissors angled
Gills-Vannas straight capsulotomy flat handle scissors
Vannas angled capsulotomy round handle scissors
Solid blade speculum designed for both temporal and superior approach ocular surgery. Adjustable with thumb screw. Manufactured in titanium.
Medicine Products: